{"id":544,"date":"2024-01-12T09:35:48","date_gmt":"2024-01-12T09:35:48","guid":{"rendered":"https:\/\/www.agb-pharma.com\/?page_id=544"},"modified":"2025-05-20T12:01:53","modified_gmt":"2025-05-20T12:01:53","slug":"transparency","status":"publish","type":"page","link":"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/","title":{"rendered":"transparency"},"content":{"rendered":"\n\n\t\t\t\t\n\t\t\t\t\"agb_logo_green\"\n\t\t\t\t<\/a>\n\t\t\t\t\t\t
SWEDEN – ENG<\/h5>\n\t\t\t

SWEDEN<\/a>
UK<\/a>
NORWAY<\/a>
DENMARK<\/a>
GERMANY<\/a>
<\/p>\n\t\t\t\t\"border2\"\n

\n\t\tTransparency\n\t<\/h1>\n\t

EFPIA Disclosure Code Reports<\/b><\/h3>\n

AGB-Pharma discloses Transfers of Value to HCP’s and HCO’s in accordance with its commitment to the EFPIA Disclosure Code and the relevant local codes of practice and\/or local legal requirements, and in accordance with all applicable data protection laws and regulations.<\/p>\n

AGB-Pharma is responsible for publishing Disclosure Reports for countries in Europe in which it operates, to strengthen the public trust in the relationships between pharmaceutical companies and HCPs and HCOs.<\/p>\n

Please choose a country below to access the individual country reports.<\/p>\n\t\t\t\t\t\t

Sweden<\/h5>\n

Documentation<\/b><\/p>\n

Methodological Note (2022)<\/a>
Sweden Transfer of Value Report (2022)<\/a><\/p>\n

Methodological Note (2023)<\/a>
Sweden Transfer of Value Report (2023)<\/a><\/p>\n

Methodological Note (2024)<\/a>
Sweden Transfer of Value Report (2024)<\/a><\/p>\n\t\t\t\t\t\t

Denmark<\/h5>\n

Documentation<\/b><\/p>\n

Methodological Note (2022)<\/a>
Denmark Transfer of Value Report (2022)<\/a><\/p>\n

Methodological Note (2023)<\/a>
Denmark Transfer of Value Report (2023)<\/a><\/p>\n

Methodological Note (2024)<\/a>
Denmark Transfer of Value Report (2024)<\/a><\/p>\n\t\t\t\t\t\t

Norway<\/h5>\n

Documentation<\/b><\/p>\n

Methodological Note (2022)<\/a>
Norway Transfer of Value Report 2022<\/a><\/p>\n

Methodological Note (2023)<\/a>
Norway Transfer of Value Report (2023)<\/a><\/p>\n

No Transfers of Value have been made 2024<\/i><\/p>\n\t

Personal Data Policy<\/a>\u00a0 |\u00a0 Transparency<\/a>\u00a0 |\u00a0 Cookie Policy<\/a>\u00a0 |\u00a0 Contact<\/a><\/p>\n\tSE-MEL-AGB 0103 05\/2025
\n\u00a9 2024 AGB-Pharma AB. Last reviewed 05\/2025\n\t\t\t\t\"logo_forskandelakemedelsforetagen\"\n\n","protected":false},"excerpt":{"rendered":"

SWEDEN – ENG SWEDENUKNORWAYDENMARKGERMANY Transparency EFPIA Disclosure Code Reports AGB-Pharma discloses Transfers of Value to HCP’s and HCO’s in accordance with its commitment to the EFPIA Disclosure Code and the relevant local codes of practice and\/or local legal requirements, and in accordance with all applicable data protection laws and regulations. AGB-Pharma is responsible for publishing…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-544","page","type-page","status-publish","hentry"],"yoast_head":"\ntransparency - AGB Pharma (SE\/ENG)<\/title>\n<meta name=\"description\" content=\"AGB-Pharma discloses Transfers of Value to HCP\u2019s and HCO\u2019s in accordance with its commitment to the EFPIA Disclosure Code and the relevant local codes of practice and\/or local legal requirements, and in accordance with all applicable data protection laws and regulations.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"transparency - AGB Pharma (SE\/ENG)\" \/>\n<meta property=\"og:description\" content=\"AGB-Pharma discloses Transfers of Value to HCP\u2019s and HCO\u2019s in accordance with its commitment to the EFPIA Disclosure Code and the relevant local codes of practice and\/or local legal requirements, and in accordance with all applicable data protection laws and regulations.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/\" \/>\n<meta property=\"og:site_name\" content=\"AGB Pharma (SE\/ENG)\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-20T12:01:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.agb-pharma.com\/se-eng\/wp-content\/uploads\/sites\/6\/2023\/12\/agb_logo_green.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/\",\"url\":\"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/\",\"name\":\"transparency - AGB Pharma (SE\/ENG)\",\"isPartOf\":{\"@id\":\"https:\/\/www.agb-pharma.com\/se-eng\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.agb-pharma.com\/se-eng\/wp-content\/uploads\/sites\/6\/2023\/12\/agb_logo_green.png\",\"datePublished\":\"2024-01-12T09:35:48+00:00\",\"dateModified\":\"2025-05-20T12:01:53+00:00\",\"description\":\"AGB-Pharma discloses Transfers of Value to HCP\u2019s and HCO\u2019s in accordance with its commitment to the EFPIA Disclosure Code and the relevant local codes of practice and\/or local legal requirements, and in accordance with all applicable data protection laws and regulations.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/#primaryimage\",\"url\":\"https:\/\/www.agb-pharma.com\/se-eng\/wp-content\/uploads\/sites\/6\/2023\/12\/agb_logo_green.png\",\"contentUrl\":\"https:\/\/www.agb-pharma.com\/se-eng\/wp-content\/uploads\/sites\/6\/2023\/12\/agb_logo_green.png\",\"width\":655,\"height\":992},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\/\/www.agb-pharma.com\/se-eng\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"transparency\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.agb-pharma.com\/se-eng\/#website\",\"url\":\"https:\/\/www.agb-pharma.com\/se-eng\/\",\"name\":\"AGB Pharma (SE\/ENG)\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.agb-pharma.com\/se-eng\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"transparency - AGB Pharma (SE\/ENG)","description":"AGB-Pharma discloses Transfers of Value to HCP\u2019s and HCO\u2019s in accordance with its commitment to the EFPIA Disclosure Code and the relevant local codes of practice and\/or local legal requirements, and in accordance with all applicable data protection laws and regulations.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/","og_locale":"sv_SE","og_type":"article","og_title":"transparency - AGB Pharma (SE\/ENG)","og_description":"AGB-Pharma discloses Transfers of Value to HCP\u2019s and HCO\u2019s in accordance with its commitment to the EFPIA Disclosure Code and the relevant local codes of practice and\/or local legal requirements, and in accordance with all applicable data protection laws and regulations.","og_url":"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/","og_site_name":"AGB Pharma (SE\/ENG)","article_modified_time":"2025-05-20T12:01:53+00:00","og_image":[{"url":"https:\/\/www.agb-pharma.com\/se-eng\/wp-content\/uploads\/sites\/6\/2023\/12\/agb_logo_green.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/","url":"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/","name":"transparency - AGB Pharma (SE\/ENG)","isPartOf":{"@id":"https:\/\/www.agb-pharma.com\/se-eng\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/#primaryimage"},"image":{"@id":"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/#primaryimage"},"thumbnailUrl":"https:\/\/www.agb-pharma.com\/se-eng\/wp-content\/uploads\/sites\/6\/2023\/12\/agb_logo_green.png","datePublished":"2024-01-12T09:35:48+00:00","dateModified":"2025-05-20T12:01:53+00:00","description":"AGB-Pharma discloses Transfers of Value to HCP\u2019s and HCO\u2019s in accordance with its commitment to the EFPIA Disclosure Code and the relevant local codes of practice and\/or local legal requirements, and in accordance with all applicable data protection laws and regulations.","breadcrumb":{"@id":"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.agb-pharma.com\/se-eng\/transparency\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/#primaryimage","url":"https:\/\/www.agb-pharma.com\/se-eng\/wp-content\/uploads\/sites\/6\/2023\/12\/agb_logo_green.png","contentUrl":"https:\/\/www.agb-pharma.com\/se-eng\/wp-content\/uploads\/sites\/6\/2023\/12\/agb_logo_green.png","width":655,"height":992},{"@type":"BreadcrumbList","@id":"https:\/\/www.agb-pharma.com\/se-eng\/transparency\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/www.agb-pharma.com\/se-eng\/"},{"@type":"ListItem","position":2,"name":"transparency"}]},{"@type":"WebSite","@id":"https:\/\/www.agb-pharma.com\/se-eng\/#website","url":"https:\/\/www.agb-pharma.com\/se-eng\/","name":"AGB Pharma (SE\/ENG)","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.agb-pharma.com\/se-eng\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/www.agb-pharma.com\/se-eng\/wp-json\/wp\/v2\/pages\/544","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.agb-pharma.com\/se-eng\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.agb-pharma.com\/se-eng\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.agb-pharma.com\/se-eng\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.agb-pharma.com\/se-eng\/wp-json\/wp\/v2\/comments?post=544"}],"version-history":[{"count":1,"href":"https:\/\/www.agb-pharma.com\/se-eng\/wp-json\/wp\/v2\/pages\/544\/revisions"}],"predecessor-version":[{"id":2152,"href":"https:\/\/www.agb-pharma.com\/se-eng\/wp-json\/wp\/v2\/pages\/544\/revisions\/2152"}],"wp:attachment":[{"href":"https:\/\/www.agb-pharma.com\/se-eng\/wp-json\/wp\/v2\/media?parent=544"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}